Literature DB >> 30421483

Ethanol-induced alterations in endocannabinoids and relevant neurotransmitters in the nucleus accumbens of fatty acid amide hydrolase knockout mice.

Francisco J Pavón1,2, Antonia Serrano1,2, David G Stouffer1, Ilham Polis1, Marisa Roberto1, Benjamin F Cravatt3, Rémi Martin-Fardon1, Fernando Rodríguez de Fonseca2, Loren H Parsons1.   

Abstract

Deletion of fatty acid amide hydrolase (FAAH), enzyme responsible for degrading endocannabinoids, increases alcohol consumption and preference. However, there is a lack of data on neurochemical events in mice exposed to alcohol in the absence of FAAH. Extracellular levels of endocannabinoids and relevant neurotransmitters were measured by in vivo microdialysis in the nucleus accumbens (NAc) of FAAH knockout (KO) and wild-type (WT) mice during an ethanol (EtOH; 2 g/kg, ip) challenge in EtOH-naive and repeated (r) EtOH-treated mice. In both genotypes, EtOH treatment caused no changes in baseline endocannabinoid levels, although FAAH KO mice displayed higher baseline N-arachidonoylethanolamine levels than WT mice. EtOH challenge caused a sustained increase in 2-arachidonoylglycerol (2-AG) levels in EtOH-naive WT mice but not in FAAH KO mice. In contrast, 2-AG levels were decreased following EtOH challenge in (r)EtOH-treated mice in both genotypes. Whereas (r)EtOH-treated mice showed higher baseline dopamine and serotonin levels than EtOH-naive mice in WT mice, these differences were attenuated in FAAH KO mice. Significant differences in baseline γ-aminobutyric acid (GABA) and glutamate levels by EtOH history were observed in WT mice but not in FAAH KO mice. Moreover, opposed effects on glutamate response were observed after EtOH challenge in EtOH-naive and (r)EtOH-treated FAAH KO mice. Finally, FAAH deletion failed to show EtOH-induced locomotion sensitivity. These data provide evidence of a potential influence of 2-AG in the neurochemical response to EtOH exposure in the NAc.
© 2018 Society for the Study of Addiction.

Entities:  

Keywords:  alcohol; endocannabinoid; fatty acid amide hydrolase (FAAH); microdialysis; nucleus accumbens

Mesh:

Substances:

Year:  2018        PMID: 30421483      PMCID: PMC6551299          DOI: 10.1111/adb.12695

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  53 in total

Review 1.  Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide.

Authors:  C J Fowler; K O Jonsson; G Tiger
Journal:  Biochem Pharmacol       Date:  2001-09-01       Impact factor: 5.858

2.  Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice.

Authors:  David J Rademacher; Sarah E Meier; Leyu Shi; W-S Vanessa Ho; Abbas Jarrahian; Cecilia J Hillard
Journal:  Neuropharmacology       Date:  2007-06-29       Impact factor: 5.250

3.  Severity of alcohol dependence is associated with the fatty acid amide hydrolase Pro129Thr missense variant.

Authors:  Matthew E Sloan; Joshua L Gowin; Jia Yan; Melanie L Schwandt; Primavera A Spagnolo; Hui Sun; Colin A Hodgkinson; David Goldman; Vijay A Ramchandani
Journal:  Addict Biol       Date:  2017-02-01       Impact factor: 4.280

4.  Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides.

Authors:  B F Cravatt; D K Giang; S P Mayfield; D L Boger; R A Lerner; N B Gilula
Journal:  Nature       Date:  1996-11-07       Impact factor: 49.962

5.  Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase.

Authors:  B F Cravatt; K Demarest; M P Patricelli; M H Bracey; D K Giang; B R Martin; A H Lichtman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

6.  Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors.

Authors:  Panayotis K Thanos; Elias S Dimitrakakis; Onarae Rice; Andrew Gifford; Nora D Volkow
Journal:  Behav Brain Res       Date:  2005-11-07       Impact factor: 3.332

7.  Transient changes in the endocannabinoid system after acute and chronic ethanol exposure and abstinence in the rat: a combined PET and microdialysis study.

Authors:  Jenny Ceccarini; Cindy Casteels; Michel Koole; Guy Bormans; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-06-06       Impact factor: 9.236

8.  Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo.

Authors:  Simona Perra; Giuliano Pillolla; Miriam Melis; Anna Lisa Muntoni; Gian Luigi Gessa; Marco Pistis
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

9.  Plasma concentrations of oleoylethanolamide and other acylethanolamides are altered in alcohol-dependent patients: effect of length of abstinence.

Authors:  Nuria Garcia-Marchena; Francisco J Pavon; Antoni Pastor; Pedro Araos; Maria Pedraz; Pablo Romero-Sanchiz; Montserrat Calado; Juan Suarez; Estela Castilla-Ortega; Laura Orio; Anna Boronat; Marta Torrens; Gabriel Rubio; Rafael de la Torre; Fernando Rodriguez de Fonseca; Antonia Serrano
Journal:  Addict Biol       Date:  2016-05-22       Impact factor: 4.280

10.  Deficient endocannabinoid signaling in the central amygdala contributes to alcohol dependence-related anxiety-like behavior and excessive alcohol intake.

Authors:  Antonia Serrano; Francisco J Pavon; Matthew W Buczynski; Joel Schlosburg; Luis A Natividad; Ilham Y Polis; David G Stouffer; Eric P Zorrilla; Marisa Roberto; Benjamin F Cravatt; Rémi Martin-Fardon; Fernando Rodriguez de Fonseca; Loren H Parsons
Journal:  Neuropsychopharmacology       Date:  2018-04-05       Impact factor: 7.853

View more
  6 in total

1.  Lower brain fatty acid amide hydrolase in treatment-seeking patients with alcohol use disorder: a positron emission tomography study with [C-11]CURB.

Authors:  Laura M Best; Belinda Williams; Bernard Le Foll; Esmaeil Mansouri; Richard P Bazinet; Lin Lin; Vincenzo De Luca; Dina Lagzdins; Pablo Rusjan; Rachel F Tyndale; Alan A Wilson; Christian S Hendershot; Markus Heilig; Sylvain Houle; Junchao Tong; Stephen J Kish; Isabelle Boileau
Journal:  Neuropsychopharmacology       Date:  2020-01-07       Impact factor: 7.853

Review 2.  Behavioral, neurobiological, and neurochemical mechanisms of ethanol self-administration: A translational review.

Authors:  Ashley A Vena; Shannon L Zandy; Roberto U Cofresí; Rueben A Gonzales
Journal:  Pharmacol Ther       Date:  2020-05-11       Impact factor: 12.310

Review 3.  Alcohol-Endocannabinoid Interactions: Implications for Addiction-Related Behavioral Processes.

Authors:  Antonia Serrano; Luis A Natividad
Journal:  Alcohol Res       Date:  2022-05-19

4.  Contribution of Fatty Acid Amide Hydrolase to Alcohol Use Disorder: A Systematic Review.

Authors:  Greta Niemela; Garth E Terry
Journal:  Cannabis Cannabinoid Res       Date:  2021-04-05

Review 5.  Patterns of Cannabis and Alcohol Co-Use: Substitution Versus Complementary Effects.

Authors:  Rachel L Gunn; Elizabeth R Aston; Jane Metrik
Journal:  Alcohol Res       Date:  2022-02-10

6.  Corticotropin-Releasing Factor Receptor-1 Neurons in the Lateral Amygdala Display Selective Sensitivity to Acute and Chronic Ethanol Exposure.

Authors:  Abigail E Agoglia; ManHua Zhu; Rose Ying; Harpreet Sidhu; Luis A Natividad; Sarah A Wolfe; Matthew W Buczynski; Candice Contet; Loren H Parsons; Marisa Roberto; Melissa A Herman
Journal:  eNeuro       Date:  2020-03-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.